Track the DIASORIN stock price and the full directors' dealings record of the company, a publicly traded company based in Italy. Shares trade on IT IT, under the authority of Consob. Operating in the Health Care sector, DIASORIN has published 22 insider filings. Market capitalisation: €3.5bn. The latest transaction was disclosed on 10 November 2025 (Other). Among the most active insiders: CARLO ROSA. All data is openly available.
22
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€26m
21 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate DIASORIN Hold (neutral), based on 12 analysts. Average price target: €69.86.
15Σ signal
Buys ·€26m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,937 of 25,973 companies
63.2
score / 100
Value
61
Quality
66
FCF yld6.1%
Earn yld4.7%
EV/EBITDA11.4x
ROE8.6%
Gross mgn65%
Net mgn13%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.